<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The revised European-American Classification of Lymphoid <z:hpo ids='HP_0002664'>Neoplasms</z:hpo> (REAL), proposed by the International <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Study Group, contains molecular genetic data which may characterize a given <z:hpo ids='HP_0002665'>lymphoma</z:hpo> entity </plain></SENT>
<SENT sid="1" pm="."><plain>In this recent review, the molecular genetic alterations integrated into the diagnostic procedure of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are discussed </plain></SENT>
<SENT sid="2" pm="."><plain>Based on our recent knowledge the rearrangements of bcl-1, bcl-2, bcl-6, anaplastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> kinase and c-myc genes are associated with mantle cell, diffuse large B-cell, anaplastic large cell and Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The integration of the relevant molecular data in the evaluation of objective diagnoses and therefore specific and successful therapies </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, the knowledge of the molecular event associated with <z:hpo ids='HP_0002665'>lymphomas</z:hpo> helps to better understand <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development and biology </plain></SENT>
</text></document>